{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["DIA-DB", "anti-diabetic", "flavonoids", "herbs", "sesquiterpenoids", "spices", "virtual screening"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31703341", "DateCompleted": {"Year": "2020", "Month": "04", "Day": "01"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "11", "Day": "07"}], "Language": ["eng"], "ELocationID": ["4030", "10.3390/molecules24224030"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "24", "Issue": "22", "PubDate": {"Year": "2019", "Month": "Nov", "Day": "07"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Evaluation of the Anti-Diabetic Activity of Some Common Herbs and Spices: Providing New Insights with Inverse Virtual Screening.", "Abstract": {"AbstractText": ["Culinary herbs and spices are widely used as a traditional medicine in the treatment of diabetes and its complications, and there are several scientific studies in the literature supporting the use of these medicinal plants. However, there is often a lack of knowledge on the bioactive compounds of these herbs and spices and their mechanisms of action. The aim of this study was to use inverse virtual screening to provide insights into the bioactive compounds of common herbs and spices, and their potential molecular mechanisms of action in the treatment of diabetes. In this study, a library of over 2300 compounds derived from 30 common herbs and spices were screened in silico with the DIA-DB web server against 18 known diabetes drug targets. Over 900 compounds from the herbs and spices library were observed to have potential anti-diabetic activity and liquorice, hops, fennel, rosemary, and fenugreek were observed to be particularly enriched with potential anti-diabetic compounds. A large percentage of the compounds were observed to be potential polypharmacological agents regulating three or more anti-diabetic drug targets and included compounds such as achillin B from yarrow, asparasaponin I from fenugreek, bisdemethoxycurcumin from turmeric, carlinoside from lemongrass, cinnamtannin B1 from cinnamon, crocin from saffron and glabridin from liquorice. The major targets identified for the herbs and spices compounds were dipeptidyl peptidase-4 (DPP4), intestinal maltase-glucoamylase (MGAM), liver receptor homolog-1 (NR5A2), pancreatic alpha-amylase (AM2A), peroxisome proliferator-activated receptor alpha (PPARA), protein tyrosine phosphatase non-receptor type 9 (PTPN9), and retinol binding protein-4 (RBP4) with over 250 compounds observed to be potential inhibitors of these particular protein targets. Only bay leaves, liquorice and thyme were found to contain compounds that could potentially regulate all 18 protein targets followed by black pepper, cumin, dill, hops and marjoram with 17 protein targets. In most cases more than one compound within a given plant could potentially regulate a particular protein target. It was observed that through this multi-compound-multi target regulation of these specific protein targets that the major anti-diabetic effects of reduced hyperglycemia and hyperlipidemia of the herbs and spices could be explained. The results of this study, taken together with the known scientific literature, indicated that the anti-diabetic potential of common culinary herbs and spices was the result of the collective action of more than one bioactive compound regulating and restoring several dysregulated and interconnected diabetic biological processes."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Pretoria Hillcrest 0083, South Africa."}], "LastName": "Pereira", "ForeName": "Andreia S P", "Initials": "ASP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Structural Bioinformatics and High-Performance Computing Research Group (BIO-HPC), Universidad Cat\u00f3lica de Murcia, 30107 Murcia, Spain."}], "LastName": "Banegas-Luna", "ForeName": "Antonio J", "Initials": "AJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Structural Bioinformatics and High-Performance Computing Research Group (BIO-HPC), Universidad Cat\u00f3lica de Murcia, 30107 Murcia, Spain."}], "LastName": "Pe\u00f1a-Garc\u00eda", "ForeName": "Jorge", "Initials": "J"}, {"Identifier": ["0000-0003-4468-7898"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Structural Bioinformatics and High-Performance Computing Research Group (BIO-HPC), Universidad Cat\u00f3lica de Murcia, 30107 Murcia, Spain."}], "LastName": "P\u00e9rez-S\u00e1nchez", "ForeName": "Horacio", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Pretoria Hillcrest 0083, South Africa."}], "LastName": "Apostolides", "ForeName": "Zeno", "Initials": "Z"}], "GrantList": [{"GrantID": "CTQ2017-87974-R", "Agency": "Spanish Ministry of Economy and Competitiveness", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "enzymology"], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Spices"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Guo X., Li H., Xu H., Woo S., Dong H., Lu F., Lange A.J., Wu C. Glycolysis in the control of blood glucose homeostasis. Acta Pharm. Sinica B. 2012;2:358\u2013367. doi: 10.1016/j.apsb.2012.06.002.", "ArticleIdList": ["10.1016/j.apsb.2012.06.002"]}, {"Citation": "Fryirs M., Barter P.J., Rye K.-A. Cholesterol metabolism and pancreatic \u03b2-cell function. Curr. Opin. Lipidol. 2009;20:159\u2013164. doi: 10.1097/MOL.0b013e32832ac180.", "ArticleIdList": ["10.1097/MOL.0b013e32832ac180", "19417651"]}, {"Citation": "Meerza D., Naseem I., Ahmed J. Pharmacology of signaling pathways: In type 2 diabetes. Diabetes Metab. Syndrome Clin. Res. Rev. 2013;3:180\u2013185. doi: 10.1016/j.dsx.2013.06.006.", "ArticleIdList": ["10.1016/j.dsx.2013.06.006", "23953186"]}, {"Citation": "World Health Organization  Fact Sheet.  [(accessed on 10 April 2019)];2017 Nov 15; Available online:  http://www.who.int/newsroom/fact-sheet/detail/diabetes."}, {"Citation": "DeFronzo R.A., Triplitt C.L., Abdul-Ghani M., Cersosimo E. Novel agents for the treatment of type 2 diabetes. Diabetes Spectrum. 2014;27:100\u2013112. doi: 10.2337/diaspect.27.2.100.", "ArticleIdList": ["10.2337/diaspect.27.2.100", "PMC4522879", "26246766"]}, {"Citation": "Gourgari E., Wilhelm E.E., Hassanzadeh H., Aroda V.R., Shoulson I. A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data. J. Diabetes Complicat. 2017;31:1719\u20131727. doi: 10.1016/j.jdiacomp.2017.08.005.", "ArticleIdList": ["10.1016/j.jdiacomp.2017.08.005", "28939018"]}, {"Citation": "Abo K., Fred-Jaiyesimi A., Jaiyesimi A. Ethnobotanical studies of medicinal plants used in the management of diabetes mellitus in South Western Nigeria. J. Ethnopharmacol. 2008;115:67\u201371. doi: 10.1016/j.jep.2007.09.005.", "ArticleIdList": ["10.1016/j.jep.2007.09.005", "17950547"]}, {"Citation": "Bahmani M., Zargaran A., Rafieian-Kopaei M., Saki K. Ethnobotanical study of medicinal plants used in the management of diabetes mellitus in the Urmia, Northwest Iran. Asian Pacific J. Tropical Med. 2014;7:S348\u2013S354. doi: 10.1016/S1995-7645(14)60257-1.", "ArticleIdList": ["10.1016/S1995-7645(14)60257-1", "25312149"]}, {"Citation": "Deutschl\u00e4nder M., Lall N., Van De Venter M. Plant species used in the treatment of diabetes by South African traditional healers: An inventory. Pharm. Biol. 2009;47:348\u2013365. doi: 10.1080/13880200902752959.", "ArticleIdList": ["10.1080/13880200902752959"]}, {"Citation": "Grover J., Yadav S., Vats V. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. 2002;81:81\u2013100. doi: 10.1016/S0378-8741(02)00059-4.", "ArticleIdList": ["10.1016/S0378-8741(02)00059-4", "12020931"]}, {"Citation": "Li W., Zheng H., Bukuru J., De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol. 2004;92:1\u201321. doi: 10.1016/j.jep.2003.12.031.", "ArticleIdList": ["10.1016/j.jep.2003.12.031", "15099842"]}, {"Citation": "Harlev E., Nevo E., Mirsky N., Ofir R. Antidiabetic attributes of desert and steppic plants: A review. Planta Med. 2013;79:425\u2013436. doi: 10.1055/s-0032-1328331.", "ArticleIdList": ["10.1055/s-0032-1328331", "23539351"]}, {"Citation": "Moradi B., Abbaszadeh S., Shahsavari S., Alizadeh M., Beyranvand F. The most useful medicinal herbs to treat diabetes. Biomed. Res. Therapy. 2018;5:2538\u20132551. doi: 10.15419/bmrat.v5i8.463.", "ArticleIdList": ["10.15419/bmrat.v5i8.463"]}, {"Citation": "Chen J., Mangelinckx S., Adams A., Wang Z.-t., Li W.-l., De Kimpe N. Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications. Nat. Prod. Commun. 2015;10:187\u2013200. doi: 10.1177/1934578X1501000140.", "ArticleIdList": ["10.1177/1934578X1501000140", "25920244"]}, {"Citation": "Gaikwad S., Krishna Mohan G., Sandhya Rani M. Phytochemicals for diabetes management. Pharm. Crops. 2014;5:11\u201328. doi: 10.2174/2210290601405010011.", "ArticleIdList": ["10.2174/2210290601405010011"]}, {"Citation": "Putta S., Sastry Yarla N., Kumar Kilari E., Surekha C., Aliev G., Basavaraju Divakara M., Sridhar Santosh M., Ramu R., Zameer F., Prasad M. Therapeutic potentials of triterpenes in diabetes and its associated complications. Curr. Topics Med. Chem. 2016;16:2532\u20132542. doi: 10.2174/1568026616666160414123343.", "ArticleIdList": ["10.2174/1568026616666160414123343", "27086788"]}, {"Citation": "Zheng Y., Bai L., Zhou Y., Tong R., Zeng M., Shi J., Lib X. Polysaccharides from Chinese herbal medicine for anti-diabetes recent advances. Int. J. Biol. Macromol. 2019;121:1240\u20131253. doi: 10.1016/j.ijbiomac.2018.10.072.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.10.072", "30342938"]}, {"Citation": "Embuscado M.E. Spices and herbs: Natural sources of antioxidants\u2013a mini review. J. Funct. Foods. 2015;18:811\u2013819. doi: 10.1016/j.jff.2015.03.005.", "ArticleIdList": ["10.1016/j.jff.2015.03.005"]}, {"Citation": "Iriti M., Vitalini S., Fico G., Faoro F. Neuroprotective herbs and foods from different traditional medicines and diets. Molecules. 2010;15:3517\u20133555. doi: 10.3390/molecules15053517.", "ArticleIdList": ["10.3390/molecules15053517", "PMC6263339", "20657497"]}, {"Citation": "Jungbauer A., Medjakovic S. Anti-inflammatory properties of culinary herbs and spices that ameliorate the effects of metabolic syndrome. Maturitas. 2012;71:227\u2013239. doi: 10.1016/j.maturitas.2011.12.009.", "ArticleIdList": ["10.1016/j.maturitas.2011.12.009", "22226987"]}, {"Citation": "Kaefer C.M., Milner J.A. The role of herbs and spices in cancer prevention. J. Nutr. Biochem. 2008;19:347\u2013361. doi: 10.1016/j.jnutbio.2007.11.003.", "ArticleIdList": ["10.1016/j.jnutbio.2007.11.003", "PMC2771684", "18499033"]}, {"Citation": "Tajkarimi M., Ibrahim S.A., Cliver D. Antimicrobial herb and spice compounds in food. Food Control. 2010;21:1199\u20131218. doi: 10.1016/j.foodcont.2010.02.003.", "ArticleIdList": ["10.1016/j.foodcont.2010.02.003"]}, {"Citation": "Tapsell L.C., Hemphill I., Cobiac L., Sullivan D.R., Fenech M., Patch C.S., Roodenrys S., Keogh J.B., Clifton P.M., Williams P.G. Health benefits of herbs and spices: The past, the present, the future.  [(accessed on 23 September 2019)]; Available online:  https://ro.uow.edu.au/hbspapers/28/", "ArticleIdList": ["17022438"]}, {"Citation": "Chen B.-W., Li W.-X., Wang G.-H., Li G.-H., Liu J.-Q., Zheng J.-J., Wang Q., Li H.-J., Dai S.-X., Huang J.-F. A strategy to find novel candidate anti-Alzheimer\u2019s disease drugs by constructing interaction networks between drug targets and natural compounds in medical plants. PeerJ. 2018;6:e4756. doi: 10.7717/peerj.4756.", "ArticleIdList": ["10.7717/peerj.4756", "PMC5951129", "29770277"]}, {"Citation": "Dai S.-X., Li W.-X., Han F.-F., Guo Y.-C., Zheng J.-J., Liu J.-Q., Wang Q., Gao Y.-D., Li G.-H., Huang J.-F. In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database. Sci. Rep. 2016;6:25462. doi: 10.1038/srep25462.", "ArticleIdList": ["10.1038/srep25462", "PMC4857115", "27145869"]}, {"Citation": "Liu J.-Q., Dai S.-X., Zheng J.-J., Guo Y.-C., Li W.-X., Li G.-H., Huang J.-F. The identification and molecular mechanism of anti-stroke traditional Chinese medicinal compounds. Sci. Rep. 2017;7:41406. doi: 10.1038/srep41406.", "ArticleIdList": ["10.1038/srep41406", "PMC5259785", "28117389"]}, {"Citation": "Broadhurst C.L., Polansky M.M., Anderson R.A. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J. Agric. Food Chem. 2000;48:849\u2013852. doi: 10.1021/jf9904517.", "ArticleIdList": ["10.1021/jf9904517", "10725162"]}, {"Citation": "Loizzo M.R., Sicari V., Tenuta M.C., Leporini M.R., Falco T., Pellican\u00f2 T.M., Menichini F., Tundis R. Phytochemicals content, antioxidant and hypoglycaemic activities of commercial nutmeg mace (Myristica fragrans L.) and pimento (Pimenta dioica (L.) Merr.) Int. J. Food Sci. Technol. 2016;51:2057\u20132063. doi: 10.1111/ijfs.13178.", "ArticleIdList": ["10.1111/ijfs.13178"]}, {"Citation": "Yogalakshmi K., Vaidehi J. Free radical scavenging activity of methanolic leaf extract of Pimenta dioica on streptozotocin-induced diabetic rats.  [(accessed on 1 August 2019)]; Available online:  http://www.jipbs.com/VolumeArticles/FullTextPDF/119_JIPBSV2I404.pdf."}, {"Citation": "Shobha R., Rajeshwari C., Andallu B. Anti-peroxidative and anti-diabetic activities of aniseeds (Pimpinella anisum L.) and identification of bioactive compounds. Amer. J. Phytomed. Clin. Therap. 2013;1:516\u2013527."}, {"Citation": "Farzaneh V., Gominho J., Pereira H., Carvalho I.S. Screening of the Antioxidant and Enzyme Inhibition Potentials of Portuguese Pimpinella anisum L. Seeds by GC-MS. Food Analy. Methods. 2018;11:2645\u20132656. doi: 10.1007/s12161-018-1250-x.", "ArticleIdList": ["10.1007/s12161-018-1250-x"]}, {"Citation": "Shobha R.I., Andallu B. Antioxidant, Anti-Diabetic and Hypolipidemic Effects of Aniseeds (Pimpinella anisum L.): In vitro and in vivo Studies. J. Complement Med. Alt. Healthcare. 2018;5:1\u201312."}, {"Citation": "El-Beshbishy H., Bahashwan S. Hypoglycemic effect of basil (Ocimum basilicum) aqueous extract is mediated through inhibition of \u03b1-glucosidase and \u03b1-amylase activities: An in vitro study. Toxicol. Ind. Health. 2012;28:42\u201350. doi: 10.1177/0748233711403193.", "ArticleIdList": ["10.1177/0748233711403193", "21636683"]}, {"Citation": "Bhatti H.A., Tehseen Y., Maryam K., Uroos M., Siddiqui B.S., Hameed A., Iqbal J. Identification of new potent inhibitor of aldose reductase from Ocimum basilicum. Bioorganic Chem. 2017;75:62\u201370. doi: 10.1016/j.bioorg.2017.08.011.", "ArticleIdList": ["10.1016/j.bioorg.2017.08.011", "28917123"]}, {"Citation": "Ademiluyi A.O., Oyeleye S.I., Oboh G. Biological activities, antioxidant properties and phytoconstituents of essential oil from sweet basil (Ocimum basilicum L.) leaves. Comparative Clin. Pathol. 2016;25:169\u2013176. doi: 10.1007/s00580-015-2163-3.", "ArticleIdList": ["10.1007/s00580-015-2163-3"]}, {"Citation": "Ezeani C., Ezenyi I., Okoye T., Okoli C. Ocimum basilicum extract exhibits antidiabetic effects via inhibition of hepatic glucose mobilization and carbohydrate metabolizing enzymes. J. Int. Ethnopharmacol. 2017;6:22. doi: 10.5455/jice.20161229054825.", "ArticleIdList": ["10.5455/jice.20161229054825", "PMC5289084", "28163956"]}, {"Citation": "Irondi E.A., Agboola S.O., Oboh G., Boligon A.A. Inhibitory effect of leaves extracts of Ocimum basilicum and Ocimum gratissimum on two key enzymes involved in obesity and hypertension in vitro. J. Int. Ethnopharmacol. 2016;5:396. doi: 10.5455/jice.20160814112756.", "ArticleIdList": ["10.5455/jice.20160814112756", "PMC5061483", "27757270"]}, {"Citation": "Kadan S., Saad B., Sasson Y., Zaid H. In vitro evaluation of anti-diabetic activity and cytotoxicity of chemically analysed Ocimum basilicum extracts. Food Chem. 2016;196:1066\u20131074. doi: 10.1016/j.foodchem.2015.10.044.", "ArticleIdList": ["10.1016/j.foodchem.2015.10.044", "26593590"]}, {"Citation": "Malapermal V., Botha I., Krishna S.B.N., Mbatha J.N. Enhancing antidiabetic and antimicrobial performance of Ocimum basilicum, and Ocimum sanctum (L.) using silver nanoparticles. Saudi J. Bio. Sci. 2017;24:1294\u20131305. doi: 10.1016/j.sjbs.2015.06.026.", "ArticleIdList": ["10.1016/j.sjbs.2015.06.026", "PMC5562380", "28855825"]}, {"Citation": "Yen H.-F., Hsieh C.-T., Hsieh T.-J., Chang F.-R., Wang C.-K. In vitro anti-diabetic effect and chemical component analysis of 29 essential oils products. J. Food Drug Analy. 2015;23:124\u2013129. doi: 10.1016/j.jfda.2014.02.004.", "ArticleIdList": ["10.1016/j.jfda.2014.02.004", "PMC9351752", "28911435"]}, {"Citation": "Ugwu M., Umar I., Utu-Baku A., Dasofunjo K., Ukpanukpong R., Yakubu O., Okafor A. Antioxidant status and organ function in streptozotocin-induced diabetic rats treated with aqueous, methanolic and petroleum ether extracts of Ocimum basilicum leaf. J. Appl. Pharm. Sci. 2013;3:S75\u2013S79."}, {"Citation": "Saraswat M., Muthenna P., Suryanarayana P., Petrash J.M., Reddy G.B. Dietary sources of aldose reductase inhibitors: Prospects for alleviating diabetic complications. Asia Pacific J. Clin. Nutri. 2008;17:55\u2013564.", "ArticleIdList": ["19114390"]}, {"Citation": "Basak S.S., Candan F. Effect of Laurus nobilis L. essential oil and its main components on \u03b1-glucosidase and reactive oxygen species scavenging activity. Iranian J. Pharm. Res. IJPR. 2013;12:367\u2013379.", "ArticleIdList": ["PMC3813252", "24250611"]}, {"Citation": "Aljamal A. Effect bay leaves on the patients with diabetes mellitus. Res. J. Med. Plants. 2011;5:471\u2013476. doi: 10.3923/rjmp.2011.471.476.", "ArticleIdList": ["10.3923/rjmp.2011.471.476"]}, {"Citation": "Khan A., Zaman G., Anderson R.A. Bay leaves improve glucose and lipid profile of people with type 2 diabetes. J. Clin. Biochem. Nutri. 2009;44:52\u201356. doi: 10.3164/jcbn.08-188.", "ArticleIdList": ["10.3164/jcbn.08-188", "PMC2613499", "19177188"]}, {"Citation": "Gupta S., Singh N., Jaggi A.S. Evaluation of in vitro aldose reductase inhibitory potential of alkaloidal fractions of Piper nigrum, Murraya koenigii, Argemone mexicana, and Nelumbo nucifera. J. Basic Clin. Physiol. Pharmacol. 2014;25:255\u2013265. doi: 10.1515/jbcpp-2013-0071.", "ArticleIdList": ["10.1515/jbcpp-2013-0071", "24127538"]}, {"Citation": "Kavitha S., Rameshkannan D.M., Mani D.P. Analysis of antioxidant and antidiabetic activity of Piper nigrum leaf extract by in-vitro assay. J. Pharm. Bio. Sci. 2018;13:53\u201356."}, {"Citation": "Oboh G., Ademosun A.O., Odubanjo O.V., Akinbola I.A. Antioxidative properties and inhibition of key enzymes relevant to type-2 diabetes and hypertension by essential oils from black pepper. Adv. Pharm. Sci. 2013;2013:1\u20136. doi: 10.1155/2013/926047.", "ArticleIdList": ["10.1155/2013/926047", "PMC3856121", "24348547"]}, {"Citation": "Mueller M., Beck V., Jungbauer A. PPAR\u03b1 activation by culinary herbs and spices. Planta Medica. 2011;77:497\u2013504. doi: 10.1055/s-0030-1250435.", "ArticleIdList": ["10.1055/s-0030-1250435", "20957597"]}, {"Citation": "Atal S., Agrawal R.P., Vyas S., Phadnis P., Rai N. Evaluation of the effect of piperine per se on blood glucose level in alloxan-induced diabetic mice. Acta Pol. Pharm. 2012;69:965\u2013969.", "ArticleIdList": ["23061294"]}, {"Citation": "Onyesife C.O., Ogugua V.N., Anaduaka E.G. Hypoglycemic potentials of ethanol leaves extract of black pepper (Piper nigrum) on alloxan-induced diabetic rats. Annals Biol. Res. 2014;5:26\u201331."}, {"Citation": "Kaleem M., Sheema S.H., Bano B. Protective effects of Piper nigrum and Vinca rosea in alloxan induced diabetic rats. Indian J. Physiol. Pharmacol. 2005;49:65\u201371.", "ArticleIdList": ["15881860"]}, {"Citation": "Sarfraz M., Khaliq T., Khan J.A., Aslam B. Effect of aqueous extract of black pepper and ajwa seed on liver enzymes in alloxan-induced diabetic Wister albino rats. Saudi Pharm. J. 2017;25:449\u2013452. doi: 10.1016/j.jsps.2017.04.004.", "ArticleIdList": ["10.1016/j.jsps.2017.04.004", "PMC5447421", "28579873"]}, {"Citation": "Veeresham C., Sujatha S., Rani T.S. Effect of piperine on the pharmacokinetics and pharmacodynamics of glimepiride in normal and streptozotocin-induced diabetic rats. Nat. Prod. Commun. 2012;7:1283\u20131286. doi: 10.1177/1934578X1200701009.", "ArticleIdList": ["10.1177/1934578X1200701009", "23156991"]}, {"Citation": "Eidi A., Eidi M., Haeri Rohani A., Basati F. Hypoglycemic effect of ethanolic extract of Carum carvi L. seeds in normal and streptozotocin-induced diabetic rats. J. Med. Plants. 2010;9:106\u2013113."}, {"Citation": "Ene A., Nwankwo E., Samdi L. Alloxan-induced diabetes in rats and the effects of Black caraway (Carum carvi L.) oil on their body weights. J. Pharmacol. Toxicol. 2008;3:141\u2013146."}, {"Citation": "Erjaee H., Rajaian H., Nazifi S., Chahardahcherik M. The effect of caraway (Carum carvi L.) on the blood antioxidant enzymes and lipid peroxidation in streptozotocin-induced diabetic rats. Comparative Clin. Pathol. 2015;24:1197\u20131203. doi: 10.1007/s00580-014-2060-1.", "ArticleIdList": ["10.1007/s00580-014-2060-1"]}, {"Citation": "Haidari F., Seyed-Sadjadi N., Taha-Jalali M., Mohammed-Shahi M. The effect of oral administration of Carum carvi on weight, serum glucose, and lipid profile in streptozotocin-induced diabetic rats. Saudi Med. J. 2011;32:695\u2013700.", "ArticleIdList": ["21748206"]}, {"Citation": "Lemhadri A., Hajji L., Michel J.-B., Eddouks M. Cholesterol and triglycerides lowering activities of caraway fruits in normal and streptozotocin diabetic rats. J. Ethnopharmacol. 2006;106:321\u2013326. doi: 10.1016/j.jep.2006.01.033.", "ArticleIdList": ["10.1016/j.jep.2006.01.033", "16567073"]}, {"Citation": "El-Yamani M. Cinnamon, cardamom and ginger impacts as evaluated on hyperglycemic rats. Res. J. Specific Educ. 2011;20:665\u2013678."}, {"Citation": "Winarsi H., Sasongko N., Purwanto A., Nuraeni I. Effect of cardamom leaves extract as antidiabetic, weight lost and hypocholesterolemic to alloxan-induced Sprague Dawley diabetic rats. Int. Food Res. J. 2014;21:2253\u20132261."}, {"Citation": "Bhat G.N., Nayak N., Vinodraj K., Chandralekha N., Mathai P., Cherian J. Comparison of the efficacy of cardamom (Elettaria cardamomum) with pioglitazone on dexamethasone-induced hepatic steatosis, dyslipidemia, and hyperglycemia in albino rats. J. Adv. Pharm. Technol. Res. 2015;6:136\u2013140. doi: 10.4103/2231-4040.157981.", "ArticleIdList": ["10.4103/2231-4040.157981", "PMC4542401", "26317079"]}, {"Citation": "Bhaswant M., Poudyal H., Mathai M., Ward L., Mouatt P., Brown L. Green and black cardamom in a diet-induced rat model of metabolic syndrome. Nutrients. 2015;7:7691\u20137707. doi: 10.3390/nu7095360.", "ArticleIdList": ["10.3390/nu7095360", "PMC4586555", "26378573"]}, {"Citation": "Gholamhoseinian A., Fallah H., Sharifi-far F., Mirtajaddini M. The inhibitory effect of some Iranian plants extracts on the alpha glucosidase. Iranian J. Basic Med. Sci. 2008;11:1\u20139."}, {"Citation": "Hamza A., Ksiksi T., Shamsi O., Balfaqh S. \u03b1-Glucosidase Inhibitory Activity of Common Traditional Medicinal Plants Used for Diabetes Mellitus. J. Dev. Drugs. 2015;4:1\u20135. doi: 10.4172/2329-6631.1000144.", "ArticleIdList": ["10.4172/2329-6631.1000144"]}, {"Citation": "Medagama A.B. The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials. Nutri. J. 2015;14:108. doi: 10.1186/s12937-015-0098-9.", "ArticleIdList": ["10.1186/s12937-015-0098-9", "PMC4609100", "26475130"]}, {"Citation": "Ponnusamy S., Ravindran R., Zinjarde S., Bhargava S., Ravi Kumar A. Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro. Evid. Based Complemen. Alter. Med. 2011;2011:1\u201310. doi: 10.1155/2011/515647.", "ArticleIdList": ["10.1155/2011/515647", "PMC2952308", "20953430"]}, {"Citation": "Seetaloo A., Aumeeruddy M., Kannan R.R., Mahomoodally M. Potential of traditionally consumed medicinal herbs, spices, and food plants to inhibit key digestive enzymes geared towards diabetes mellitus management\u2014A systematic review. South African J. Botany. 2019;120:3\u201324. doi: 10.1016/j.sajb.2018.05.015.", "ArticleIdList": ["10.1016/j.sajb.2018.05.015"]}, {"Citation": "Salehi P., Asghari B., Esmaeili M.A., Dehghan H., Ghazi I. \u03b1-Glucosidase and \u03b1-amylase inhibitory effect and antioxidant activity of ten plant extracts traditionally used in Iran for diabetes. J. Med. Plants Res. 2013;7:257\u2013266."}, {"Citation": "Tahir H.U., Sarfraz R.A., Ashraf A., Adil S. Chemical composition and antidiabetic Activity of essential oils obtained from two spices (Syzygium aromaticum and Cuminum cyminum) Int. J. Food Propert. 2016;19:2156\u20132164. doi: 10.1080/10942912.2015.1110166.", "ArticleIdList": ["10.1080/10942912.2015.1110166"]}, {"Citation": "Adefegha S.A., Oboh G. Inhibition of key enzymes linked to type 2 diabetes and sodium nitroprusside-induced lipid peroxidation in rat pancreas by water extractable phytochemicals from some tropical spices. Pharm. Biol. 2012;50:857\u2013865. doi: 10.3109/13880209.2011.641022.", "ArticleIdList": ["10.3109/13880209.2011.641022", "22480175"]}, {"Citation": "Adefegha S.A., Oboh G. In vitro inhibition activity of polyphenol-rich extracts from Syzygium aromaticum (L.) Merr. & Perry (Clove) buds against carbohydrate hydrolyzing enzymes linked to type 2 diabetes and Fe2+-induced lipid peroxidation in rat pancreas. Asian Pacific J. Tropical Biomed. 2012;2:774\u2013781.", "ArticleIdList": ["PMC3609220", "23569846"]}, {"Citation": "Prasad R.C., Herzog B., Boone B., Sims L., Waltner-Law M. An extract of Syzygium aromaticum represses genes encoding hepatic gluconeogenic enzymes. J. Ethnopharmacol. 2005;96:295\u2013301. doi: 10.1016/j.jep.2004.09.024.", "ArticleIdList": ["10.1016/j.jep.2004.09.024", "15588682"]}, {"Citation": "Kuroda M., Mimaki Y., Ohtomo T., Yamada J., Nishiyama T., Mae T., Kishida H., Kawada T. Hypoglycemic effects of clove (Syzygium aromaticum flower buds) on genetically diabetic KK-A y mice and identification of the active ingredients. J. Nat. Med. 2012;66:394\u2013399. doi: 10.1007/s11418-011-0593-z.", "ArticleIdList": ["10.1007/s11418-011-0593-z", "21987283"]}, {"Citation": "Al-Attar A.M., Zari T.A. Modulatory effects of ginger and clove oils on physiological responses in streptozotocin-induced diabetic rats. Int. J. Pharmacol. 2007;3:34\u201340."}, {"Citation": "Khathi A., Serumula M.R., Myburg R.B., Van Heerden F.R., Musabayane C.T. Effects of Syzygium aromaticum-derived triterpenes on postprandial blood glucose in streptozotocin-induced diabetic rats following carbohydrate challenge. PLoS ONE. 2013;8:e81632. doi: 10.1371/journal.pone.0081632.", "ArticleIdList": ["10.1371/journal.pone.0081632", "PMC3838356", "24278452"]}, {"Citation": "Mkhwanazi B.N., Serumula M.R., Myburg R.B., Van Heerden F.R., Musabayane C.T. Antioxidant effects of maslinic acid in livers, hearts and kidneys of streptozotocin-induced diabetic rats: Effects on kidney function. Renal Failure. 2014;36:419\u2013431. doi: 10.3109/0886022X.2013.867799.", "ArticleIdList": ["10.3109/0886022X.2013.867799", "24344651"]}, {"Citation": "Ngubane P.S., Masola B., Musabayane C.T. The effects of Syzygium aromaticum-derived oleanolic acid on glycogenic enzymes in streptozotocin-induced diabetic rats. Renal Failure. 2011;33:434\u2013439. doi: 10.3109/0886022X.2011.568147.", "ArticleIdList": ["10.3109/0886022X.2011.568147", "21529273"]}, {"Citation": "Adefegha S.A., Oboh G., Adefegha O.M., Boligon A.A., Athayde M.L. Antihyperglycemic, hypolipidemic, hepatoprotective and antioxidative effects of dietary clove (Szyzgium aromaticum) bud powder in a high-fat diet/streptozotocin-induced diabetes rat model. J. Sci. Food Agric. 2014;94:2726\u20132737. doi: 10.1002/jsfa.6617.", "ArticleIdList": ["10.1002/jsfa.6617", "24532325"]}, {"Citation": "Ranilla L.G., Kwon Y.-I., Apostolidis E., Shetty K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresource Technol. 2010;101:4676\u20134689. doi: 10.1016/j.biortech.2010.01.093.", "ArticleIdList": ["10.1016/j.biortech.2010.01.093", "20185303"]}, {"Citation": "Hemlata B., Pornima G., Tukaram K., Pankaj B. In vitro anti-amylase activity of some Indian dietary spices. J. Appl. Biol. Biotechnol. Vol. 2019;7:70\u201374."}, {"Citation": "Lee H.-S. Cuminaldehyde: Aldose reductase and \u03b1-glucosidase inhibitor derived from Cuminum cyminum L. seeds. J. Agric. Food Chem. 2005;53:2446\u20132450. doi: 10.1021/jf048451g.", "ArticleIdList": ["10.1021/jf048451g", "15796577"]}, {"Citation": "Srivsatava R., Srivastava S.P., Jaiswal N., Mishra A., Maurya R., Srivastava A.K. Antidiabetic and antidyslipidemic activities of Cuminum cyminum L. in validated animal models. Med. Chem. Res. 2011;20:1656\u20131666. doi: 10.1007/s00044-010-9483-2.", "ArticleIdList": ["10.1007/s00044-010-9483-2"]}, {"Citation": "Rau O., Wurglics M., Dingermann T., Abdel-Tawab M., Schubert-Zsilavecz M. Screening of herbal extracts for activation of the human peroxisome proliferator-activated receptor. Die Pharmazie An Int. J. Pharm. Sci. 2006;61:952\u2013956.", "ArticleIdList": ["17152989"]}, {"Citation": "Jagtap A., Patil P. Antihyperglycemic activity and inhibition of advanced glycation end product formation by Cuminum cyminum in streptozotocin induced diabetic rats. Food Chem. Toxicol. 2010;48:2030\u20132036. doi: 10.1016/j.fct.2010.04.048.", "ArticleIdList": ["10.1016/j.fct.2010.04.048", "20451573"]}, {"Citation": "Bahrami E., Khedri M.R., Zangeneh M.M., Abiari M., Zangeneh A., Amiri-Paryan A., Tahvilian R., Moradi R. Effect of Anethum graveolens aqueous extract on blood fasting glucose and hematological parameters in diabetic male BALB/c mice. Onl. J. Vet. Res. 2017;21:784\u2013793."}, {"Citation": "Goodarzi M.T., Khodadadi I., Tavilani H., Abbasi Oshaghi E. The role of Anethum graveolens L. (Dill) in the management of diabetes. J. Tropical Med. 2016;2016:1\u201311. doi: 10.1155/2016/1098916.", "ArticleIdList": ["10.1155/2016/1098916", "PMC5088306", "27829842"]}, {"Citation": "Mishra N. Haematological and hypoglycemic potential Anethum graveolens seeds extract in normal and diabetic Swiss albino mice. Veterinary World. 2013;6:502\u2013507. doi: 10.5455/vetworld.2013.502-507.", "ArticleIdList": ["10.5455/vetworld.2013.502-507"]}, {"Citation": "Oshaghi E.A., Tavilani H., Khodadadi I., Goodarzi M.T. Dill tablet: A potential antioxidant and anti-diabetic medicine. Asian Pacific J. Tropical Biomed. 2015;5:720\u2013727. doi: 10.1016/j.apjtb.2015.06.012.", "ArticleIdList": ["10.1016/j.apjtb.2015.06.012"]}, {"Citation": "Abu-Zaiton A., Alu\u2019datt M., Wafa M. Evaluating the effect of Foeniculum vulgare extract on enzymes related with blood pressure and diabetes (in vitro study) Int. J. Chem. Eng. Biol. Sci. 2015;2:77\u201380."}, {"Citation": "Godavari A., Amutha K., Moorthi N.M. In-vitro hypoglycemic effect of Foeniculum vulgare Mill. Seeds on the carbohydrate hydrolysing enzymes, alpha-amylase and alpha-glucosidase. Int. J. Pharm. Sci. Res. 2018;9:4441\u20134445."}, {"Citation": "Al-Aridhi D.T. The Effect of Foeniculum Vulgare Alcoholic Extract on Some Metabolic Changes in Liver and Kidneys of Alloxan Diabetic Mice. Iraqi J. Med. Sci. 2014;12:119\u2013125."}, {"Citation": "Anitha T., Balakumar C., Ilango K., Jose C.B., Vetrivel D. Antidiabetic activity of the aqueous extracts of Foeniculum vulgare on streptozotocin-induced diabetic rats. Int. J. Adv. Pharm. Biol. Chem. 2014;3:487\u2013494."}, {"Citation": "El-Soud N., El-Laithy N., El-Saeed G., Wahby M., Khalil M., Morsy F., Shaffie N. Antidiabetic activities of Foeniculum vulgare Mill. essential oil in streptozotocin-induced diabetic rats. Macedonian J. Med. Sci. 2011;4:139\u2013146."}, {"Citation": "Parsaeyan N. The effect of Foeniculum vulgare (fennel) extract on lipid profile, lipid peroxidation and liver enzymes of diabetic rat. Iranian J. Diabetes Obesity. 2016;8:24\u201329."}, {"Citation": "Ganeshpurkar A., Diwedi V., Bhardwaj Y. In vitro \u03b1-amylase and \u03b1-glucosidase inhibitory potential of Trigonella foenum-graecum leaves extract. Ayu. 2013;34:109\u2013112. doi: 10.4103/0974-8520.115446.", "ArticleIdList": ["10.4103/0974-8520.115446", "PMC3764866", "24049415"]}, {"Citation": "Bansode T.S., Gupta A., Chaphalkar S., Salalkar B. Integrating in-silico and in-vitro approaches to screen the antidiabetic drug from Trigonella foenum graecum Linn. Int. J. Biochem. Res. Rev. 2016;14:1\u201310. doi: 10.9734/IJBCRR/2016/29875.", "ArticleIdList": ["10.9734/IJBCRR/2016/29875"]}, {"Citation": "Gad M.Z., El-Sawalhi M.M., Ismail M.F., El-Tanbouly N.D. Biochemical study of the anti-diabetic action of the Egyptian plants Fenugreek and Balanites. Mol. Cell. Biochem. 2006;281:173\u2013183. doi: 10.1007/s11010-006-0996-4.", "ArticleIdList": ["10.1007/s11010-006-0996-4", "16328970"]}, {"Citation": "Kamtekar S., Keer V., Patil V. Estimation of phenolic content, flavonoid content, antioxidant and alpha amylase inhibitory activity of marketed polyherbal formulation. J. Appl. Pharm. Sci. 2014;4:61\u201365."}, {"Citation": "Hamden K., Keskes H., Elgomdi O., Feki A., Alouche N. Modulatory effect of an isolated triglyceride from fenugreek seed oil on of \u03b1-amylase, lipase and ace activities, liver-kidney functions and metabolic disorders of diabetic rats. J. Oleo Sci. 2017;66:633\u2013645. doi: 10.5650/jos.ess16254.", "ArticleIdList": ["10.5650/jos.ess16254", "28566642"]}, {"Citation": "Buchholz T., Melzig M.F. Medicinal plants traditionally used for treatment of obesity and diabetes mellitus\u2013screening for pancreatic lipase and \u03b1-Amylase inhibition. Phytotherapy Res. 2016;30:260\u2013266. doi: 10.1002/ptr.5525.", "ArticleIdList": ["10.1002/ptr.5525", "26632284"]}, {"Citation": "Christensen K.B., Minet A., Svenstrup H., Grevsen K., Zhang H., Schrader E., Rimbach G., Wein S., Wolffram S., Kristiansen K. Identification of plant extracts with potential antidiabetic properties: Effect on human peroxisome proliferator-activated receptor (PPAR), adipocyte differentiation and insulin-stimulated glucose uptake. Phytotherapy Res. 2009;23:1316\u20131325. doi: 10.1002/ptr.2782.", "ArticleIdList": ["10.1002/ptr.2782", "19172665"]}, {"Citation": "Hamden K., Jaouadi B., Carreau S., Bejar S., Elfeki A. Inhibitory effect of fenugreek galactomannan on digestive enzymes related to diabetes, hyperlipidemia, and liver-kidney dysfunctions. Biotechnol. Bioproc. Eng. 2010;15:407\u2013413. doi: 10.1007/s12257-009-3037-9.", "ArticleIdList": ["10.1007/s12257-009-3037-9"]}, {"Citation": "Hamden K., Jaouadi B., Salami T., Carreau S., Bejar S., Elfeki A. Modulatory effect of fenugreek saponins on the activities of intestinal and hepatic disaccharidase and glycogen and liver function of diabetic rats. Biotechnol. Bioproc. Eng. 2010;15:745\u2013753. doi: 10.1007/s12257-009-3159-0.", "ArticleIdList": ["10.1007/s12257-009-3159-0"]}, {"Citation": "Hamden K., Keskes H., Belhaj S., Mnafgui K., Allouche N. Inhibitory potential of omega-3 fatty and fenugreek essential oil on key enzymes of carbohydrate-digestion and hypertension in diabetes rats. Lipids Health Disease. 2011;10:1\u201310. doi: 10.1186/1476-511X-10-226.", "ArticleIdList": ["10.1186/1476-511X-10-226", "PMC3240899", "22142357"]}, {"Citation": "Tharaheswari M., Kumar J.S.P., Reddy N.J., Subhashree S., Rani S.S. Fenugreek seed extract stabilize plasma lipid levels in type 2 diabetes by modulating PPARs and GLUT4 in insulin target tissues. AJPCT. 2014;2:587\u2013602."}, {"Citation": "Alu\u2019datt M.H., Rababah T., Alhamad M.N., Gammoh S., Ereifej K., Johargy A., Kubow S., Almajwal A.M., Rawashdeh M. Optimization of Phenolic Content, Antioxidant, and Inhibitory Activities of \u03b1-Glucosidase and Angiotensin Converting (AC) Enzymes from Zingiber officinale Z. Int. J. Food Propert. 2016;19:1303\u20131316. doi: 10.1080/10942912.2015.1063066.", "ArticleIdList": ["10.1080/10942912.2015.1063066"]}, {"Citation": "Elya B., Handayani R., Sauriasari R., Hasyyati U.S., Permana I.T., Permatasari Y.I. Antidiabetic activity and phytochemical screening of extracts from Indonesian plants by inhibition of alpha amylase, alpha glucosidase and dipeptidyl peptidase IV. Pakistan J. Bio. Sci. 2015;18:279\u2013284. doi: 10.3923/pjbs.2015.279.284.", "ArticleIdList": ["10.3923/pjbs.2015.279.284"]}, {"Citation": "Adefegha A. Inhibitory effects of aqueous extract of two varieties of ginger on some key enzymes linked to type-2 diabetes in vitro. J. Food Nutri. Res. 2010;49:14\u201320."}, {"Citation": "Priya Rani M., Padmakumari K., Sankarikutty B., Lijo Cherian O., Nisha V., Raghu K. Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. Int. J. Food Sci. Nutri. 2011;62:106\u2013110. doi: 10.3109/09637486.2010.515565.", "ArticleIdList": ["10.3109/09637486.2010.515565", "20874376"]}, {"Citation": "Kato A., Higuchi Y., Goto H., Kizu H., Okamoto T., Asano N., Hollinshead J., Nash R.J., Adachi I. Inhibitory effects of Zingiber officinale Roscoe derived components on aldose reductase activity in vitro and in vivo. J. Agric. Food Chem. 2006;54:6640\u20136644. doi: 10.1021/jf061599a.", "ArticleIdList": ["10.1021/jf061599a", "16939321"]}, {"Citation": "Son M.J., Miura Y., Yagasaki K. Mechanisms for antidiabetic effect of gingerol in cultured cells and obese diabetic model mice. Cytotechnology. 2015;67:641\u2013652. doi: 10.1007/s10616-014-9730-3.", "ArticleIdList": ["10.1007/s10616-014-9730-3", "PMC4474985", "24794903"]}, {"Citation": "Keskin \u015e., \u015eirin Y., \u00c7akir H., Keskin M. An investigation of Humulus lupulus L.: Phenolic composition, antioxidant capacity and inhibition properties of clinically important enzymes. South African J. Botany. 2019;120:170\u2013174. doi: 10.1016/j.sajb.2018.04.017.", "ArticleIdList": ["10.1016/j.sajb.2018.04.017"]}, {"Citation": "Seliger J.M., Misuri L., Maser E., Hintzpeter J. The hop-derived compounds xanthohumol, isoxanthohumol and 8-prenylnaringenin are tight-binding inhibitors of human aldo-keto reductases 1B1 and 1B10. J. Enzyme Inhibit. Med. Chem. 2018;33:607\u2013614. doi: 10.1080/14756366.2018.1437728.", "ArticleIdList": ["10.1080/14756366.2018.1437728", "PMC6010053", "29532688"]}, {"Citation": "Liu M., Yin H., Liu G., Dong J., Qian Z., Miao J. Xanthohumol, a prenylated chalcone from beer hops, acts as an \u03b1-glucosidase inhibitor in vitro. J. Agric. Food Chem. 2014;62:5548\u20135554. doi: 10.1021/jf500426z.", "ArticleIdList": ["10.1021/jf500426z", "24897556"]}, {"Citation": "Lima-Fontes M.r., Costa R., Rodrigues I., Soares R. Xanthohumol restores hepatic glucolipid metabolism balance in type 1 diabetic wistar rats. J. Agric. Food Chem. 2017;65:7433\u20137439. doi: 10.1021/acs.jafc.7b02595.", "ArticleIdList": ["10.1021/acs.jafc.7b02595", "28745504"]}, {"Citation": "Sun H., Wang D., Song X., Zhang Y., Ding W., Peng X., Zhang X., Li Y., Ma Y., Wang R. Natural prenylchalconaringenins and prenylnaringenins as antidiabetic agents: \u03b1-glucosidase and \u03b1-amylase inhibition and in vivo antihyperglycemic and antihyperlipidemic effects. J. Agric. Food Chem. 2017;65:1574\u20131581. doi: 10.1021/acs.jafc.6b05445.", "ArticleIdList": ["10.1021/acs.jafc.6b05445", "28132506"]}, {"Citation": "Yajima H., Ikeshima E., Shiraki M., Kanaya T., Fujiwara D., Odai H., Tsuboyama-Kasaoka N., Ezaki O., Oikawa S., Kondo K. Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated receptor \u03b1 and \u03b3 and reduce insulin resistance. J. Bio. Chem. 2004;279:33456\u201333462. doi: 10.1074/jbc.M403456200.", "ArticleIdList": ["10.1074/jbc.M403456200", "15178687"]}, {"Citation": "Nozawa H. Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-Ay mice. Biochem. Biophys. Res. Commun. 2005;336:754\u2013761. doi: 10.1016/j.bbrc.2005.08.159.", "ArticleIdList": ["10.1016/j.bbrc.2005.08.159", "16140264"]}, {"Citation": "Takahashi K., Osada K. Effect of dietary purified xanthohumol from hop (Humulus lupulus L.) pomace on adipose tissue mass, fasting blood glucose level, and lipid metabolism in KK-Ay mice. J. Oleo Sci. 2017;66:531\u2013541. doi: 10.5650/jos.ess16234.", "ArticleIdList": ["10.5650/jos.ess16234", "28413193"]}, {"Citation": "Kwon Y.-I.I., Vattem D.A., Shetty K. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pacific J. Clin. Nutri. 2006;15:107\u2013118.", "ArticleIdList": ["16500886"]}, {"Citation": "Weidner C., Wowro S.J., Freiwald A., Kodelja V., Abdel-Aziz H., Kelber O., Sauer S. Lemon balm extract causes potent antihyperglycemic and antihyperlipidemic effects in insulin-resistant obese mice. Mol. Nutri. Food Res. 2014;58:903\u2013907. doi: 10.1002/mnfr.201300477.", "ArticleIdList": ["10.1002/mnfr.201300477", "24272914"]}, {"Citation": "Hasanein P., Riahi H. Antinociceptive and antihyperglycemic effects of Melissa officinalis essential oil in an experimental model of diabetes. Med. Prin. Practice. 2015;24:47\u201352. doi: 10.1159/000368755.", "ArticleIdList": ["10.1159/000368755", "PMC5588194", "25402675"]}, {"Citation": "Khodsooz S., Moshtaghian J., Eivani M. Antihyperglycemic and antihyperlipidemic effects of hydroalcoholic extract of Melissa officinalis (Lemon Balm) in alloxan-induced diabetic rats. Physiol. Pharmacol. 2016;20:24\u201330."}, {"Citation": "Tashakor A., Kelishadi M.R., Ghasemi A., Daylami F., Rahimi A., Doabi S.Z., Abdolusefi N.N. Effects of hydroalcoholic extract in Mellissa officinalis plant on fat profiles and glucose level in diabetic rats induced by streptozotocin. J. Chem. Pharm. Res. 2016;8:402\u2013406."}, {"Citation": "Boaduo N.K.K., Katerere D., Eloff J.N., Naidoo V. Evaluation of six plant species used traditionally in the treatment and control of diabetes mellitus in South Africa using in vitro methods. Pharm. Biol. 2014;52:756\u2013761. doi: 10.3109/13880209.2013.869828.", "ArticleIdList": ["10.3109/13880209.2013.869828", "24559378"]}, {"Citation": "Jagdale A.D., Kamble S.P., Nalawade M.L., Arvindekar A.U. Citronellol: A potential antioxidant and aldose reductase inhibitor from Cymbopogon citratus. Int. J. Pharm. Pharm. Sci. 2015;7:203\u2013209."}, {"Citation": "Santoso F., Winarno J., Gunawan-Puteri M.D. Application of Lemongrass (Cymbopogon Citratus) As A Functional Food Ingredient With Alpha-Glucosidase Inhibitory Activity. Adv. Eng. Res. 2018;172:205\u2013209."}, {"Citation": "Jumepaeng T., Prachakool S., Luthria D.L., Chanthai S. Determination of antioxidant capacity and \u03b1-amylase inhibitory activity of the essential oils from citronella grass and lemongrass. Int. Food Res. J. 2013;20:481\u2013485."}, {"Citation": "Bharti S., Kumar A., Prakash O., Krishnan S., Gupta A. Essential oil of cymbopogon citratus against diabetes: Validation by in vivo experiments and computational studies. J Bioanal. Biomed. 2013;5:194\u2013203."}, {"Citation": "Kuroda M., Mimaki Y., Honda S., Tanaka H., Yokota S., Mae T. Phenolics from Glycyrrhiza glabra roots and their PPAR-\u03b3 ligand-binding activity. Bioorganic Med. Chem. 2010;18:962\u2013970. doi: 10.1016/j.bmc.2009.11.027.", "ArticleIdList": ["10.1016/j.bmc.2009.11.027", "20022509"]}, {"Citation": "Ko B.-S., Jang J.S., Hong S.M., Sung S.R., Lee J.E., Lee M.Y., Jeon W.K., Park S. Changes in components, glycyrrhizin and glycyrrhetinic acid, in raw Glycyrrhiza uralensis Fisch, modify insulin sensitizing and insulinotropic actions. Biosci. Biotechnol. Biochem. 2007;6:1452\u20131461. doi: 10.1271/bbb.60533.", "ArticleIdList": ["10.1271/bbb.60533", "17587675"]}, {"Citation": "Yoon G., Lee W., Kim S.-N., Cheon S.H. Inhibitory effect of chalcones and their derivatives from Glycyrrhiza inflata on protein tyrosine phosphatase 1B. Bioorganic Med. Chem. Lett. 2009;19:5155\u20135157. doi: 10.1016/j.bmcl.2009.07.054.", "ArticleIdList": ["10.1016/j.bmcl.2009.07.054", "19632832"]}, {"Citation": "Lee Y.S., Kim S.H., Jung S.H., Kim J.K., Pan C.-H., Lim S.S. Aldose reductase inhibitory compounds from Glycyrrhiza uralensis. Bio. Pharm. Bullet. 2010;33:917\u2013921. doi: 10.1248/bpb.33.917.", "ArticleIdList": ["10.1248/bpb.33.917", "20460778"]}, {"Citation": "Mohammed F.Z., El-Shehabi M. Antidiabetic activity of caffeic acid and 18\u03b2-glycyrrhetinic acid and its relationship with the antioxidant property. Asian J. Pharm. Clin. Res. 2015;8:229\u2013235."}, {"Citation": "Kalaiarasi P., Kaviarasan K., Pugalendi K.V. Hypolipidemic activity of 18\u03b2-glycyrrhetinic acid on streptozotocin-induced diabetic rats. Europ. J. Pharmacol. 2009;612:93\u201397. doi: 10.1016/j.ejphar.2009.04.003.", "ArticleIdList": ["10.1016/j.ejphar.2009.04.003", "19361497"]}, {"Citation": "Gaur R., Yadav K.S., Verma R.K., Yadav N.P., Bhakuni R.S. In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin. Phytomedicine. 2014;21:415\u2013422. doi: 10.1016/j.phymed.2013.10.015.", "ArticleIdList": ["10.1016/j.phymed.2013.10.015", "24262065"]}, {"Citation": "El-Ghffar E.A.A. Ameliorative effect of glabridin, a main component of Glycyrrhiza glabra L. roots in streptozotocin induced Type 1 diabetes in male albino rats. Ind. J. Tradition. Knowledge. 2016;15:570\u2013579."}, {"Citation": "Rani R., Dahiya S., Dhingra D., Dilbaghi N., Kim K.-H., Kumar S. Evaluation of anti-diabetic activity of glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic rats. Europ. J. Pharm. Sci. 2017;106:220\u2013230. doi: 10.1016/j.ejps.2017.05.068.", "ArticleIdList": ["10.1016/j.ejps.2017.05.068", "28595874"]}, {"Citation": "Nakagawa K., Kishida H., Arai N., Nishiyama T., Mae T. Licorice flavonoids suppress abdominal fat accumulation and increase in blood glucose level in obese diabetic KK-Ay mice. Bio. Pharm. Bullet. 2004;27:1775\u20131778. doi: 10.1248/bpb.27.1775.", "ArticleIdList": ["10.1248/bpb.27.1775", "15516721"]}, {"Citation": "Kataya H.H., Hamza A.A., Ramadan G.A., Khasawneh M.A. Effect of licorice extract on the complications of diabetes nephropathy in rats. Drug Chem. Toxicol. 2011;34:101\u2013108. doi: 10.3109/01480545.2010.510524.", "ArticleIdList": ["10.3109/01480545.2010.510524", "21314459"]}, {"Citation": "Sen S., Roy M., Chakraborti A.S. Ameliorative effects of glycyrrhizin on streptozotocin-induced diabetes in rats. J. Pharm. Pharmacol. 2011;63:287\u2013296. doi: 10.1111/j.2042-7158.2010.01217.x.", "ArticleIdList": ["10.1111/j.2042-7158.2010.01217.x", "21235594"]}, {"Citation": "Sil R., Ray D., Chakraborti A.S. Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model. Ind. J. Experimental Biol. 2013;51:129\u2013138.", "ArticleIdList": ["23923606"]}, {"Citation": "Bower A.M., Real Hernandez L.M., Berhow M.A., De Mejia E.G. Bioactive compounds from culinary herbs inhibit a molecular target for type 2 diabetes management, dipeptidyl peptidase IV. J. Agric. Food Chem. 2014;62:6147\u20136158. doi: 10.1021/jf500639f.", "ArticleIdList": ["10.1021/jf500639f", "24881464"]}, {"Citation": "Kawabata J., Mizuhata K., Sato E., Nishioka T., Aoyama Y., Kasai T. 6-Hydroxyflavonoids as \u03b1-glucosidase inhibitors from marjoram (Origanum majorana) leaves. Biosci. Biotechnol. Biochem. 2003;67:445\u2013447. doi: 10.1271/bbb.67.445.", "ArticleIdList": ["10.1271/bbb.67.445", "12729019"]}, {"Citation": "Pimple B., Kadam P., Patil M. Comparative antihyperglycaemic and antihyperlipidemic effect of Origanum majorana extracts in NIDDM rats. Oriental Pharm. Experimental Med. 2012;12:41\u201350. doi: 10.1007/s13596-011-0047-x.", "ArticleIdList": ["10.1007/s13596-011-0047-x"]}, {"Citation": "Soliman M.M., Nassan M.A., Ismail T.A. Origanum Majoranum extract modulates gene expression, hepatic and renal changes in a rat model of type 2 diabetes. Iranian J. Pharm. Res. IJPR. 2016;15:45.", "ArticleIdList": ["PMC5242351", "28228803"]}, {"Citation": "Tripathy B., Satyanarayana S., Khan K.A., Raja K. Evaluation of anti-diabetic and anti-hyperlipidemic activities of ethanolic leaf extract of Origanum Majorana in streptozotocin induced diabetic rats. Int. J. Pharm. Sci. Res. 2018;9:1529\u20131536."}, {"Citation": "Han K.L., Choi J.S., Lee J.Y., Song J., Joe M.K., Jung M.H., Hwang J.-K. Therapeutic potential of peroxisome proliferators\u2013activated receptor-\u03b1/\u03b3 dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes. Diabetes. 2008;57:737\u2013745. doi: 10.2337/db07-0972.", "ArticleIdList": ["10.2337/db07-0972", "18065517"]}, {"Citation": "Lestari K., Hwang J., Kariadi S.H., Wijaya A., Ahmad T., Subarnas A., Supriyatna M., Muchtaridi M. Screening for PPAR \u03b3 agonist from Myristica fragrans Houtt seeds for the treatment of Type 2 diabetes by in vitro and in vivo. Med. Health Sci. J. 2012;12:7\u201315. doi: 10.15208/mhsj.2012.37.", "ArticleIdList": ["10.15208/mhsj.2012.37"]}, {"Citation": "Nguyen P.H., Le T.V.T., Kang H.W., Chae J., Kim S.K., Kwon K.-i., Seo D.B., Lee S.J., Oh W.K. AMP-activated protein kinase (AMPK) activators from Myristica fragrans (nutmeg) and their anti-obesity effect. Bioorganic Med. Chem. Lett. 2010;20:4128\u20134131. doi: 10.1016/j.bmcl.2010.05.067.", "ArticleIdList": ["10.1016/j.bmcl.2010.05.067", "20541406"]}, {"Citation": "Patil S.B., Ghadyale V.A., Taklikar S.S., Kulkarni C.R., Arvindekar A.U. Insulin secretagogue, alpha-glucosidase and antioxidant activity of some selected spices in streptozotocin-induced diabetic rats. Plant Foods Human Nutri. 2011;66:85\u201390. doi: 10.1007/s11130-011-0215-7.", "ArticleIdList": ["10.1007/s11130-011-0215-7", "21437656"]}, {"Citation": "Shyni G., Sasidharan K., Francis S.K., Das A.A., Nair M.S., Raghu K. Licarin B from Myristica fragrans improves insulin sensitivity via PPAR\u03b3 and activation of GLUT4 in the IRS-1/PI3K/AKT pathway in 3T3-L1 adipocytes. RSC Adv. 2016;6:79859\u201379870. doi: 10.1039/C6RA13055K.", "ArticleIdList": ["10.1039/C6RA13055K"]}, {"Citation": "Yang S., Min Kyun N., Jang J.P., Kim K.A., Kim B.Y., Sung N.J., Oh W.K., Ahn J.S. Inhibition of protein tyrosine phosphatase 1B by lignans from Myristica fragrans. Phytotherapy Res. 2006;20:680\u2013682. doi: 10.1002/ptr.1935.", "ArticleIdList": ["10.1002/ptr.1935", "16752372"]}, {"Citation": "Arulmozhi D., Kurian R., Veeranjaneyulu A., Bodhankar S. Antidiabetic and antihyperlipidemic effects of Myristica fragrans. in animal models. Pharm. Biol. 2007;45:64\u201368. doi: 10.1080/13880200601028339.", "ArticleIdList": ["10.1080/13880200601028339"]}, {"Citation": "Somani R., Singhai A. Hypoglycaemic and antidiabetic activities of seeds of Myristica fragrans in normoglycaemic and alloxan-induced diabetic rats. Asian J. Exp. Sci. 2008;22:95\u2013102."}, {"Citation": "McCue P., Vattem D., Shetty K. Inhibitory effect of clonal oregano extracts against porcine pancreatic amylase in vitro. Asia Pacific J. Clin. Nutri. 2004;13:401\u2013408.", "ArticleIdList": ["15563448"]}, {"Citation": "Koukoulitsa C., Zika C., Geromichalos G.D., Demopoulos V.J., Skaltsa H. Evaluation of aldose reductase inhibition and docking studies of some secondary metabolites, isolated from Origanum vulgare L. ssp. hirtum. Bioorganic Med. Chem. 2006;14:1653\u20131659. doi: 10.1016/j.bmc.2005.10.013.", "ArticleIdList": ["10.1016/j.bmc.2005.10.013", "16249088"]}, {"Citation": "Koukoulitsa C., Zika C., Hadjipavlou\u2013Litina D., Demopoulos V.J., Skaltsa H. Inhibitory effect of polar oregano extracts on aldose reductase and soybean lipoxygenase in vitro. Phytotherapy Res. 2006;20:605\u2013606. doi: 10.1002/ptr.1901.", "ArticleIdList": ["10.1002/ptr.1901", "16691547"]}, {"Citation": "Sarikurkcu C., Zengin G., Oskay M., Uysal S., Ceylan R., Aktumsek A. Composition, antioxidant, antimicrobial and enzyme inhibition activities of two Origanum vulgare subspecies (subsp. vulgare and subsp. hirtum) essential oils. Ind. Crops Prod. 2015;70:178\u2013184. doi: 10.1016/j.indcrop.2015.03.030.", "ArticleIdList": ["10.1016/j.indcrop.2015.03.030"]}, {"Citation": "Koga K., Shibata H., Yoshino K., Nomoto K. Effects of 50% Ethanol Extract from Rosemary (Rosmarinus officinalis) on \u03b1-Glucosidase Inhibitory Activity and the Elevation of Plasma Glucose Level in Rats, and Its Active Compound. J. Food Sci. 2006;71:S507\u2013S512. doi: 10.1111/j.1750-3841.2006.00125.x.", "ArticleIdList": ["10.1111/j.1750-3841.2006.00125.x"]}, {"Citation": "Kwon Y.I., Apostolidis E., Shetty K. Evaluation of pepper (Capsicum annuum) for management of diabetes and hypertension. J. Food Biochem. 2007;31:370\u2013385. doi: 10.1111/j.1745-4514.2007.00120.x.", "ArticleIdList": ["10.1111/j.1745-4514.2007.00120.x"]}, {"Citation": "Tundis R., Loizzo M.R., Menichini F., Bonesi M., Conforti F., Statti G., De Luca D., de Cindio B., Menichini F. Comparative study on the chemical composition, antioxidant properties and hypoglycaemic activities of two Capsicum annuum L. cultivars (Acuminatum small and Cerasiferum) Plant Foods Human Nutri. 2011;66:261\u2013269. doi: 10.1007/s11130-011-0248-y.", "ArticleIdList": ["10.1007/s11130-011-0248-y", "21792679"]}, {"Citation": "Magied M.M.A., Salama N.A.R., Ali M.R. Hypoglycemic and hypocholesterolemia effects of intragastric administration of dried red chili pepper (Capsicum annum) in alloxan-induced diabetic male albino rats fed with high-fat-diet. J. Food Nutri. Res. 2014;2:850\u2013856. doi: 10.12691/jfnr-2-11-15.", "ArticleIdList": ["10.12691/jfnr-2-11-15"]}, {"Citation": "Bolkent S., Yanardag R., Ozsoy-Sacan O., Karabulut-Bulan O. Effects of parsley (Petroselinum crispum) on the liver of diabetic rats: A morphological and biochemical study. Phytotherapy Res. 2004;18:996\u2013999. doi: 10.1002/ptr.1598.", "ArticleIdList": ["10.1002/ptr.1598", "15742348"]}, {"Citation": "Abou Khalil N.S., Abou-Elhamd A.S., Wasfy S.I., El Mileegy I.M., Hamed M.Y., Ageely H.M. Antidiabetic and antioxidant impacts of desert date (Balanites aegyptiaca) and parsley (Petroselinum sativum) aqueous extracts: Lessons from experimental rats. J. Diabetes Res. 2016;2016:1\u201310. doi: 10.1155/2016/8408326.", "ArticleIdList": ["10.1155/2016/8408326", "PMC4785268", "27019854"]}, {"Citation": "Ozsoy-Sacan O., Yanardag R., Orak H., Ozgey Y., Yarat A., Tunali T. Effects of parsley (Petroselinum crispum) extract versus glibornuride on the liver of streptozotocin-induced diabetic rats. J. Ethnopharmacol. 2006;104:175\u2013181. doi: 10.1016/j.jep.2005.08.069.", "ArticleIdList": ["10.1016/j.jep.2005.08.069", "16223573"]}, {"Citation": "Soliman H.A., Eltablawy N.A., Hamed M.S. The ameliorative effect of Petroselinum crispum (parsley) on some diabetes complications. J. Med. Plants Studies. 2015;3:92\u2013100."}, {"Citation": "Yanarda\u011f R., Bolkent \u015e., Tabako\u011flu-O\u011fuz A., \u00d6zsoy-Sa\u00e7an \u00d6. Effects of Petroselinum crispum extract on pancreatic B cells and blood glucose of streptozotocin-induced diabetic rats. Bio. Pharm. Bullet. 2003;26:1206\u20131210. doi: 10.1248/bpb.26.1206.", "ArticleIdList": ["10.1248/bpb.26.1206", "12913280"]}, {"Citation": "Cazzola R., Camerotto C., Cestaro B. Anti-oxidant, anti-glycant, and inhibitory activity against \u03b1-amylase and \u03b1-glucosidase of selected spices and culinary herbs. Int. J. Food Sci. Nutri. 2011;62:175\u2013184. doi: 10.3109/09637486.2010.529068.", "ArticleIdList": ["10.3109/09637486.2010.529068", "21118052"]}, {"Citation": "Tu Z., Moss-Pierce T., Ford P., Jiang T.A. Rosemary (Rosmarinus officinalis L.) extract regulates glucose and lipid metabolism by activating AMPK and PPAR pathways in HepG2 cells. J. Agric. Food Chem. 2013;61:2803\u20132810. doi: 10.1021/jf400298c.", "ArticleIdList": ["10.1021/jf400298c", "23432097"]}, {"Citation": "Bustanji Y., Issa A., Mohammad M., Hudaib M., Tawah K., Alkhatib H., Almasri I., Al-Khalidi B. Inhibition of hormone sensitive lipase and pancreatic lipase by Rosmarinus officinalis extract and selected phenolic constituents. J. Med. Plants Res. 2010;4:2235\u20132242."}, {"Citation": "Al-Jamal A.-R., Alqadi T. Effects of rosemary (Rosmarinus officinalis) on lipid profile of diabetic rats. Jordan J. Bio. Sci. 2011;147:1\u20135."}, {"Citation": "Emam M.A. Comparative evaluation of antidiabetic activity of Rosmarinus officinalis L. and Chamomile recutita in streptozotocin induced diabetic rats. Agric. Biol. JN Am. 2012;3:247\u2013252. doi: 10.5251/abjna.2012.3.6.247.252.", "ArticleIdList": ["10.5251/abjna.2012.3.6.247.252"]}, {"Citation": "Kensara O., ElSawy N., Altaf F., Header E. Hypoglycemic and hepato-protective effects of Rosmarinus officinalis in experimental diabetic Rats. UQU Med. J. 2010;1:98\u2013113."}, {"Citation": "Ramadan K.S., Khalil O.A., Danial E.N., Alnahdi H.S., Ayaz N.O. Hypoglycemic and hepatoprotective activity of Rosmarinus officinalis extract in diabetic rats. J. Physiol. Biochem. 2013;69:779\u2013783. doi: 10.1007/s13105-013-0253-8.", "ArticleIdList": ["10.1007/s13105-013-0253-8", "23625639"]}, {"Citation": "Hassani F.V., Shirani K., Hosseinzadeh H. Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: A review. Naunyn-Schmiedeberg\u2019s Archives Pharmacol. 2016;389:931\u2013949. doi: 10.1007/s00210-016-1256-0.", "ArticleIdList": ["10.1007/s00210-016-1256-0", "27178264"]}, {"Citation": "Kang C., Lee H., Jung E.-S., Seyedian R., Jo M., Kim J., Kim J.-S., Kim E. Saffron (Crocus sativus L.) increases glucose uptake and insulin sensitivity in muscle cells via multipathway mechanisms. Food Chem. 2012;135:2350\u20132358. doi: 10.1016/j.foodchem.2012.06.092.", "ArticleIdList": ["10.1016/j.foodchem.2012.06.092", "22980812"]}, {"Citation": "Elgazar A.F., Rezq A.A., Bukhari H.M. Anti-hyperglycemic effect of saffron extract in alloxan-induced diabetic rats. Eur. J. Biol. Sci. 2013;5:14\u201322."}, {"Citation": "Kianbakht S., Hajiaghaee R. Anti-hyperglycemic effects of saffron and its active constituents, crocin and safranal, in alloxan-induced diabetic rats. J. Med. Plants. 2011;3:82\u201389."}, {"Citation": "Mohajeri D., Mousavi G., Doustar Y. Antihyperglycemic and pancreas-protective effects of Crocus sativus L.(Saffron) stigma ethanolic extract on rats with alloxan-induced diabetes. J. Biol. Sci. 2009;9:302\u2013310. doi: 10.3923/jbs.2009.302.310.", "ArticleIdList": ["10.3923/jbs.2009.302.310"]}, {"Citation": "Mohammad R., Daryoush M., Ali R., Yousef D., Mehrdad N. Attenuation of oxidative stress of hepatic tissue by ethanolic extract of saffron (dried stigmas of Crocus sativus L.) in streptozotocin (STZ)-induced diabetic rats. African J. Pharm. Pharmacol. 2011;5:2166\u20132173."}, {"Citation": "Samarghandian S., Borji A., Delkhosh M.B., Samini F. Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats. J. Pharm. Pharm. Sci. 2013;16:352\u2013362. doi: 10.18433/J3ZS3Q.", "ArticleIdList": ["10.18433/J3ZS3Q", "23958204"]}, {"Citation": "Samarghandian S., Azimi-Nezhad M., Samini F. Ameliorative effect of saffron aqueous extract on hyperglycemia, hyperlipidemia, and oxidative stress on diabetic encephalopathy in streptozotocin induced experimental diabetes mellitus. BioMed. Res. Int. 2014;2014:1\u201312. doi: 10.1155/2014/920857.", "ArticleIdList": ["10.1155/2014/920857", "PMC4119909", "25114929"]}, {"Citation": "Khacheba I., Djeridane A., Yousfi M. Twenty traditional Algerian plants used in diabetes therapy as strong inhibitors of \u03b1-amylase activity. Int. J. Carbohydrate Chem. 2014;2014:1\u201312. doi: 10.1155/2014/287281.", "ArticleIdList": ["10.1155/2014/287281"]}, {"Citation": "Christensen K.B., J\u00f8rgensen M., Kotowska D., Petersen R.K., Kristiansen K., Christensen L.P. Activation of the nuclear receptor PPAR\u03b3 by metabolites isolated from sage (Salvia officinalis L.) J. Ethnopharmacol. 2010;132:127\u2013133. doi: 10.1016/j.jep.2010.07.054.", "ArticleIdList": ["10.1016/j.jep.2010.07.054", "20696231"]}, {"Citation": "Moradabadi L., Kouhsari S.M., Sani M.F. Hypoglycemic effects of three medicinal plants in experimental diabetes: Inhibition of rat intestinal \u03b1-glucosidase and enhanced pancreatic Insulin and cardiac Glut-4 mRNAs expression. Iranian J. Pharm. Res. IJPR. 2013;12:387\u2013397.", "ArticleIdList": ["PMC3813273", "24250646"]}, {"Citation": "Eidi A., Eidi M. Antidiabetic effects of sage (Salvia officinalis L.) leaves in normal and streptozotocin-induced diabetic rats. Diabetes Metab. Syndrome Clin. Res. Rev. 2009;3:40\u201344. doi: 10.1016/j.dsx.2008.10.007.", "ArticleIdList": ["10.1016/j.dsx.2008.10.007"]}, {"Citation": "Aljarah A.K., Hameed I.H. In Vitro Anti-diabetic Properties of Methanolic Extract of Thymus vulgaris Using \u03b1-glucosidase and \u03b1-amylase Inhibition Assay and Determination of its Bioactive Chemical Compounds. Ind. J. Public Health Res. Develop. 2018;9:388\u2013392. doi: 10.5958/0976-5506.2018.00241.3.", "ArticleIdList": ["10.5958/0976-5506.2018.00241.3"]}, {"Citation": "El-Houri R.B., Kotowska D., Olsen L.C., Bhattacharya S., Christensen L.P., Grevsen K., Oksbjerg N., F\u00e6rgeman N., Kristiansen K., Christensen K.B. Screening for bioactive metabolites in plant extracts modulating glucose uptake and fat accumulation. Evid. Based Complemen. Alter. Med. 2014;2014:1\u20138. doi: 10.1155/2014/156398.", "ArticleIdList": ["10.1155/2014/156398", "PMC4164421", "25254050"]}, {"Citation": "Ekoh S.N., Akubugwo E.I., Ude V.C., Edwin N. Anti-hyperglycemic and anti-hyperlipidemic effect of spices (Thymus vulgaris, Murraya koenigii, Ocimum gratissimum and Piper guineense) in alloxan-induced diabetic rats. Int. J. Biosci. 2014;4:179\u2013187."}, {"Citation": "Hanna E.T., Aniess W., Khalil A.F., Abdalla E.S., Hassanin E.A., Nagib E.W. The effect of ginger and thyme on some biochemical parameters in diabetic rats. IOSR J. Pharm. Biol. Sci. 2014;9:54\u201361. doi: 10.9790/3008-09335461.", "ArticleIdList": ["10.9790/3008-09335461"]}, {"Citation": "Ozkol H., Tuluce Y., Dilsiz N., Koyuncu I. Therapeutic potential of some plant extracts used in Turkish traditional medicine on streptozocin-induced type 1 diabetes mellitus in rats. J. Membrane Biol. 2013;246:47\u201355. doi: 10.1007/s00232-012-9503-x.", "ArticleIdList": ["10.1007/s00232-012-9503-x", "23052826"]}, {"Citation": "Lekshmi P., Arimboor R., Indulekha P., Nirmala Menon A. Turmeric (Curcuma longa L.) volatile oil inhibits key enzymes linked to type 2 diabetes. Int. J. Food Sci. Nutri. 2012;63:832\u2013834. doi: 10.3109/09637486.2011.607156.", "ArticleIdList": ["10.3109/09637486.2011.607156", "22385048"]}, {"Citation": "Lekshmi P., Arimboor R., Raghu K., Menon A.N. Turmerin, the antioxidant protein from turmeric (Curcuma longa) exhibits antihyperglycaemic effects. Nat. Prod. Res. 2012;26:1654\u20131658. doi: 10.1080/14786419.2011.589386.", "ArticleIdList": ["10.1080/14786419.2011.589386", "21972920"]}, {"Citation": "Mohankumar S., McFarlane J.R. An aqueous extract of Curcuma longa (turmeric) rhizomes stimulates insulin release and mimics insulin action on tissues involved in glucose homeostasis in vitro. Phytotherapy Res. 2011;25:396\u2013401. doi: 10.1002/ptr.3275.", "ArticleIdList": ["10.1002/ptr.3275", "20734343"]}, {"Citation": "Ponnusamy S., Zinjarde S., Bhargava S., Rajamohanan P., RaviKumar A. Discovering Bisdemethoxycurcumin from Curcuma longa rhizome as a potent small molecule inhibitor of human pancreatic \u03b1-amylase, a target for type-2 diabetes. Food Chem. 2012;135:2638\u20132642. doi: 10.1016/j.foodchem.2012.06.110.", "ArticleIdList": ["10.1016/j.foodchem.2012.06.110", "22980852"]}, {"Citation": "Du Z.Y., Bao Y.D., Liu Z., Qiao W., Ma L., Huang Z.S., Gu L.Q., Chan A.S. Curcumin analogs as potent aldose reductase inhibitors. Archiv der Pharmazie. 2006;339:123\u2013128. doi: 10.1002/ardp.200500205.", "ArticleIdList": ["10.1002/ardp.200500205", "16528793"]}, {"Citation": "Du Z.-y., Liu R.-r., Shao W.-y., Mao X.-p., Ma L., Gu L.-q., Huang Z.-s., Chan A.S. \u03b1-Glucosidase inhibition of natural curcuminoids and curcumin analogs. Europ. J. Med. Chem. 2006;41:213\u2013218. doi: 10.1016/j.ejmech.2005.10.012.", "ArticleIdList": ["10.1016/j.ejmech.2005.10.012", "16387392"]}, {"Citation": "Halder N., Joshi S., Gupta S. Lens aldose reductase inhibiting potential of some indigenous plants. J. Ethnopharmacol. 2003;86:113\u2013116. doi: 10.1016/S0378-8741(03)00052-7.", "ArticleIdList": ["10.1016/S0378-8741(03)00052-7", "12686449"]}, {"Citation": "Madkor H.R., Mansour S.W., Ramadan G. Modulatory effects of garlic, ginger, turmeric and their mixture on hyperglycaemia, dyslipidaemia and oxidative stress in streptozotocin\u2013nicotinamide diabetic rats. British J. Nutri. 2011;105:1210\u20131217. doi: 10.1017/S0007114510004927.", "ArticleIdList": ["10.1017/S0007114510004927", "21144104"]}, {"Citation": "Nishiyama T., Mae T., Kishida H., Tsukagawa M., Mimaki Y., Kuroda M., Sashida Y., Takahashi K., Kawada T., Nakagawa K. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J. Agric. Food Chem. 2005;53:959\u2013963. doi: 10.1021/jf0483873.", "ArticleIdList": ["10.1021/jf0483873", "15713005"]}, {"Citation": "Rai P., Jaiswal D., Mehta S., Rai D., Sharma B., Watal G. Effect of Curcuma longa freeze dried rhizome powder with milk in STZ induced diabetic rats. Ind. J. Clin. Biochem. 2010;25:175\u2013181. doi: 10.1007/s12291-010-0032-z.", "ArticleIdList": ["10.1007/s12291-010-0032-z", "PMC3453095", "23105906"]}, {"Citation": "Kuroda M., Mimaki Y., Nishiyama T., Mae T., Kishida H., Tsukagawa M., Takahashi K., Kawada T., Nakagawa K., Kitahara M. Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Bio. Pharm. Bullet. 2005;28:937\u2013939. doi: 10.1248/bpb.28.937.", "ArticleIdList": ["10.1248/bpb.28.937", "15863912"]}, {"Citation": "Babu P.S., Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol. Cell. Biochem. 1997;166:169\u2013175. doi: 10.1023/A:1006819605211.", "ArticleIdList": ["10.1023/A:1006819605211", "9046034"]}, {"Citation": "Arun N., Nalini N. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Human Nutri. 2002;57:41\u201352. doi: 10.1023/A:1013106527829.", "ArticleIdList": ["10.1023/A:1013106527829", "11855620"]}, {"Citation": "Ch\u00e1vez-Silva F., Cer\u00f3n-Romero L., Arias-Dur\u00e1n L., Navarrete-V\u00e1zquez G., Almanza-P\u00e9rez J., Rom\u00e1n-Ramos R., Ram\u00edrez-\u00c1vila G., Perea-Arango I., Villalobos-Molina R., Estrada-Soto S. Antidiabetic effect of Achillea millefollium through multitarget interactions: \u03b1-glucosidases inhibition, insulin sensitization and insulin secretagogue activities. J. Ethnopharmacol. 2018;212:1\u20137. doi: 10.1016/j.jep.2017.10.005.", "ArticleIdList": ["10.1016/j.jep.2017.10.005", "29031783"]}, {"Citation": "Mustafa K.G., Ganai B.A., Akbar S., Dar M.Y., Masood A. \u03b2-Cell protective efficacy, hypoglycemic and hypolipidemic effects of extracts of Achillea millifolium in diabetic rats. Chinese J. Nat. Med. 2012;10:185\u2013189."}, {"Citation": "Zolghadri Y., Fazeli M., Kooshki M., Shomali T., Karimaghayee N., Dehghani M. Achillea millefolium L. hydro-alcoholic extract protects pancreatic cells by down regulating IL-1\u03b2 and iNOS gene expression in diabetic rats. Int. J. Mol. Cell. Med. 2014;3:255\u2013262.", "ArticleIdList": ["PMC4293613", "25635252"]}, {"Citation": "Aljamal A. Effects of bay leaves on blood glucose and lipid profiles on the patients with type 1 diabetes. World Acad. Sci. Eng. Technol. 2010;69:211\u2013214."}, {"Citation": "Azimi P., Ghiasvand R., Feizi A., Hariri M., Abbasi B. Effects of cinnamon, cardamom, saffron, and ginger consumption on markers of glycemic control, lipid profile, oxidative stress, and inflammation in type 2 diabetes patients. Rev. Diabetic Studies RDS. 2014;11:258\u2013266. doi: 10.1900/RDS.2014.11.258.", "ArticleIdList": ["10.1900/RDS.2014.11.258", "PMC5397291", "26177486"]}, {"Citation": "Andallu B., Ramya V. Antihyperglycemic, cholesterol-lowering and HDL-raising effects of cumin (Cuminum cyminum) seeds in type-2 diabetes. J. Nat. Remed. 2007;7:142\u2013149."}, {"Citation": "Jafari S., Sattari R., Ghavamzadeh S.i. Evaluation the effect of 50 and 100 mg doses of Cuminum cyminum essential oil on glycemic indices, insulin resistance and serum inflammatory factors on patients with diabetes type II: A double-blind randomized placebo-controlled clinical trial. J. Trad. Complemen. Med. 2017;7:332\u2013338. doi: 10.1016/j.jtcme.2016.08.004.", "ArticleIdList": ["10.1016/j.jtcme.2016.08.004", "PMC5506625", "28725629"]}, {"Citation": "Mobasseri M., Payahoo L., Ostadrahimi A., Bishak Y.K., Jafarabadi M.A., Mahluji S. Anethum graveolens supplementation improves insulin sensitivity and lipid abnormality in type 2 diabetic patients. Pharm. Sci. 2014;20:40."}, {"Citation": "Al Jamal A. Effect of rosemary (Rosmarinus officinalis) on lipid profiles and blood glucose in human diabetic patients (type-2) African J. Biochem. Res. 2014;8:147\u2013150."}, {"Citation": "Milajerdi A., Jazayeri S., Hashemzadeh N., Shirzadi E., Derakhshan Z., Djazayeri A., Akhondzadeh S. The effect of saffron (Crocus sativus L.) hydroalcoholic extract on metabolic control in type 2 diabetes mellitus: A triple-blinded randomized clinical trial. J. Res. Med. Sci. 2018;23:1\u20136.", "ArticleIdList": ["PMC5842443", "29531568"]}, {"Citation": "Behradmanesh S., Derees F., Rafieian-kopaei M. Effect of Salvia officinalis on diabetic patients. J. Renal Injury Prevention. 2013;2:51\u201354.", "ArticleIdList": ["PMC4206016", "25340127"]}, {"Citation": "Kianbakht S., Dabaghian F.H. Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: A randomized placebo. Controlled clinical trial. Complement. Therapies Med. 2013;21:441\u2013446. doi: 10.1016/j.ctim.2013.07.004.", "ArticleIdList": ["10.1016/j.ctim.2013.07.004", "24050577"]}, {"Citation": "Chuengsamarn S., Rattanamongkolgul S., Luechapudiporn R., Phisalaphong C., Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 2012;35:2121\u20132127. doi: 10.2337/dc12-0116.", "ArticleIdList": ["10.2337/dc12-0116", "PMC3476912", "22773702"]}, {"Citation": "Van Poelje P.D., Dang Q., Erion M.D. Fructose-1, 6-bisphosphatase as a therapeutic target for type 2 diabetes. Drug Discovery Today Therapeutic Strategies. 2007;4:103\u2013109. doi: 10.1016/j.ddstr.2007.10.003.", "ArticleIdList": ["10.1016/j.ddstr.2007.10.003", "17659484"]}, {"Citation": "Brunham L.R., Kruit J.K., Hayden M.R., Verchere C.B. Cholesterol in \u03b2-cell dysfunction: The emerging connection between HDL cholesterol and Type 2 diabetes. Curr. Diabetes Rep. 2010;10:55\u201360. doi: 10.1007/s11892-009-0090-x.", "ArticleIdList": ["10.1007/s11892-009-0090-x", "20425068"]}, {"Citation": "Chui P.C., Guan H.-P., Lehrke M., Lazar M.A. PPAR\u03b3 regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1. J. Clin. Invest. 2005;115:2244\u20132256. doi: 10.1172/JCI24130.", "ArticleIdList": ["10.1172/JCI24130", "PMC1172230", "16007265"]}, {"Citation": "Senthil S.L., Raghu C., Arjun H., Anantharaman P. In vitro and in silico inhibition properties of fucoidan against \u03b1-amylase and \u03b1-D-glucosidase with relevance to type 2 diabetes mellitus. Carbohydrate Polymers. 2019;209:350\u2013355.", "ArticleIdList": ["30732817"]}, {"Citation": "S\u00e1nchez-P\u00e9rez A., Mu\u00f1oz A., Pe\u00f1a-Garc\u00eda J., den-Haan H., Bekas N., Katsikoudi A., Tzakos A.G., P\u00e9r\u00e9z-S\u00e1nchez H. Proceedings of International Conference on Bioinformatics and Biomedical Engineering. Springer; New York, NY, USA: 2015. DIA-DB: A Web-Accessible Database for the Prediction of Diabetes Drugs; pp. 655\u2013663."}, {"Citation": "Oosterveer M.H., Mataki C., Yamamoto H., Harach T., Moullan N., van Dijk T.H., Ayuso E., Bosch F., Postic C., Groen A.K. LRH-1\u2013dependent glucose sensing determines intermediary metabolism in liver. J. Clin. Invest. 2012;122:2817\u20132826. doi: 10.1172/JCI62368.", "ArticleIdList": ["10.1172/JCI62368", "PMC3408738", "22772466"]}, {"Citation": "Xu J., Lin S., Myers R.W., Trujillo M.E., Pachanski M.J., Malkani S., Chen H.-s., Chen Z., Campbell B., Eiermann G.J. Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes Mellitus. Bioorganic Med. Chem. Lett. 2017;27:2063\u20132068. doi: 10.1016/j.bmcl.2016.10.088.", "ArticleIdList": ["10.1016/j.bmcl.2016.10.088", "28284809"]}, {"Citation": "Degenhardt T., Saram\u00e4ki A., Malinen M., Rieck M., V\u00e4is\u00e4nen S., Huotari A., Herzig K.-H., M\u00fcller R., Carlberg C. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor \u03b2/\u03b4. J. Mol. Biol. 2007;372:341\u2013355. doi: 10.1016/j.jmb.2007.06.091.", "ArticleIdList": ["10.1016/j.jmb.2007.06.091", "17669420"]}, {"Citation": "Wagner R., Hieronimus A., Lamprinou A., Heni M., Hatziagelaki E., Ullrich S., Stefan N., Staiger H., H\u00e4ring H.-U., Fritsche A. Peroxisome proliferator-activated receptor gamma (PPARG) modulates free fatty acid receptor 1 (FFAR1) dependent insulin secretion in humans. Mol. Metab. 2014;3:676\u2013680. doi: 10.1016/j.molmet.2014.07.001.", "ArticleIdList": ["10.1016/j.molmet.2014.07.001", "PMC4142395", "25161890"]}, {"Citation": "Kota B.P., Huang T.H.-W., Roufogalis B.D. An overview on biological mechanisms of PPARs. Pharmacol. Res. 2005;51:85\u201394. doi: 10.1016/j.phrs.2004.07.012.", "ArticleIdList": ["10.1016/j.phrs.2004.07.012", "15629253"]}, {"Citation": "Moller D.E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature. 2001;414:821\u2013827. doi: 10.1038/414821a.", "ArticleIdList": ["10.1038/414821a", "11742415"]}, {"Citation": "Aronoff S.L., Berkowitz K., Shreiner B., Want L. Glucose metabolism and regulation: Beyond insulin and glucagon. Diabetes Spectrum. 2004;17:183\u2013190. doi: 10.2337/diaspect.17.3.183.", "ArticleIdList": ["10.2337/diaspect.17.3.183"]}, {"Citation": "Wagner R., Kaiser G., Gerst F., Christiansen E., Due-Hansen M.E., Grundmann M., Machicao F., Peter A., Kostenis E., Ulven T. Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans. Diabetes. 2013;62:2106\u20132111. doi: 10.2337/db12-1249.", "ArticleIdList": ["10.2337/db12-1249", "PMC3661642", "23378609"]}, {"Citation": "Stulnig T., Waldh\u00e4usl W. 11\u03b2-hydroxysteroid dehydrogenase type 1 in obesity and type 2 diabetes. Diabetologia. 2004;47:1\u201311. doi: 10.1007/s00125-003-1284-4.", "ArticleIdList": ["10.1007/s00125-003-1284-4", "14652720"]}, {"Citation": "Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414:799\u2013806. doi: 10.1038/414799a.", "ArticleIdList": ["10.1038/414799a", "11742412"]}, {"Citation": "Herman M.A., Kahn B.B. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J. Clin. Invest. 2006;116:1767\u20131775. doi: 10.1172/JCI29027.", "ArticleIdList": ["10.1172/JCI29027", "PMC1483149", "16823474"]}, {"Citation": "Yabe-Nishimura C. Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacol. Rev. 1998;50:21\u201334.", "ArticleIdList": ["9549756"]}, {"Citation": "Etxeberria U., de la Garza A.L., Campi\u00f3n J., Martinez J.A., Milagro F.I. Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase. Expert Opin. Therapeutic Targets. 2012;16:269\u2013297. doi: 10.1517/14728222.2012.664134.", "ArticleIdList": ["10.1517/14728222.2012.664134", "22360606"]}, {"Citation": "Jeoung N.H. Pyruvate dehydrogenase kinases: Therapeutic targets for diabetes and cancers. Diabetes Metab. J. 2015;39:188\u2013197. doi: 10.4093/dmj.2015.39.3.188.", "ArticleIdList": ["10.4093/dmj.2015.39.3.188", "PMC4483603", "26124988"]}, {"Citation": "Martin J., Veluraja K., Ross K., Johnson L., Fleet G., Ramsden N., Bruce I., Orchard M., Oikonomakos N. Glucose analog inhibitors of glycogen phosphorylase: The design of potential drugs for diabetes. Biochemistry. 1991;30:10101\u201310116. doi: 10.1021/bi00106a006.", "ArticleIdList": ["10.1021/bi00106a006", "1931942"]}, {"Citation": "Mellado-Gil J.M., Cobo-Vuilleumier N., Gauthier B.R. Islet B-cell mass preservation and regeneration in diabetes mellitus: Four factors with potential therapeutic interest. J. Transplantation. 2012;2012:230870. doi: 10.1155/2012/230870.", "ArticleIdList": ["10.1155/2012/230870", "PMC3420151", "22919462"]}, {"Citation": "Monsalve F.A., Pyarasani R.D., Delgado-Lopez F., Moore-Carrasco R. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases. Med. Inflamm. 2013;2013:549627. doi: 10.1155/2013/549627.", "ArticleIdList": ["10.1155/2013/549627", "PMC3678499", "23781121"]}, {"Citation": "Csermely P., Agoston V., Pongor S. The efficiency of multi-target drugs: The network approach might help drug design. Trends Pharmacol. Sci. 2005;26:178\u2013182. doi: 10.1016/j.tips.2005.02.007.", "ArticleIdList": ["10.1016/j.tips.2005.02.007", "15808341"]}, {"Citation": "Peters J.-U. Polypharmacology\u2013foe or friend? J. Med. Chem. 2013;56:8955\u20138971. doi: 10.1021/jm400856t.", "ArticleIdList": ["10.1021/jm400856t", "23919353"]}, {"Citation": "Reddy A.S., Zhang S. Polypharmacology: Drug discovery for the future. Expert Rev. Clin. Pharmacol. 2013;6:41\u201347. doi: 10.1586/ecp.12.74.", "ArticleIdList": ["10.1586/ecp.12.74", "PMC3809828", "23272792"]}, {"Citation": "Xu J., Han J., Epstein P.N., Liu Y.Q. Regulation of PDK mRNA by high fatty acid and glucose in pancreatic islets. Biochem. Biophys. Res. Commun. 2006;344:827\u2013833. doi: 10.1016/j.bbrc.2006.03.211.", "ArticleIdList": ["10.1016/j.bbrc.2006.03.211", "16631612"]}, {"Citation": "Wu C.-Y., Tso S.-C., Chuang J.L., Gui W.-J., Lou M., Sharma G., Khemtong C., Qi X., Wynn R.M., Chuang D.T. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice. Mol. Metab. 2018;12:12\u201324. doi: 10.1016/j.molmet.2018.03.014.", "ArticleIdList": ["10.1016/j.molmet.2018.03.014", "PMC6001905", "29656110"]}, {"Citation": "Evans R.M., Barish G.D., Wang Y.-X. PPARs and the complex journey to obesity. Keio J. Med. 2004;53:53\u201358. doi: 10.2302/kjm.53.53.", "ArticleIdList": ["10.2302/kjm.53.53", "15264367"]}, {"Citation": "Yoon S.-Y., Lee J.H., Kwon S.J., Kang H.J., Chung S.J. Ginkgolic acid as a dual-targeting inhibitor for protein tyrosine phosphatases relevant to insulin resistance. Bioorganic Chem. 2018;81:264\u2013269. doi: 10.1016/j.bioorg.2018.08.011.", "ArticleIdList": ["10.1016/j.bioorg.2018.08.011", "30153591"]}, {"Citation": "Abbas G., Hussain H., Hamaed A., Supuran C.T. The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, \u03b1-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2) Bioorganic Chem. 2019;86:305\u2013315. doi: 10.1016/j.bioorg.2019.02.009.", "ArticleIdList": ["10.1016/j.bioorg.2019.02.009", "30738330"]}, {"Citation": "Zhu Q., Ge F., Dong Y., Sun W., Wang Z., Shan Y., Chen R., Sun J., Ge R.-S. Comparison of flavonoids and isoflavonoids to inhibit rat and human 11\u03b2-hydroxysteroid dehydrogenase 1 and 2. Steroids. 2018;132:25\u201332. doi: 10.1016/j.steroids.2018.01.013.", "ArticleIdList": ["10.1016/j.steroids.2018.01.013", "29425740"]}, {"Citation": "Tamori Y., Sakaue H., Kasuga M. RBP4, an unexpected adipokine. Nat. Med. 2006;12:30\u201331. doi: 10.1038/nm0106-30.", "ArticleIdList": ["10.1038/nm0106-30", "16397554"]}, {"Citation": "Berry D.C., Noy N. Signaling by vitamin A and retinol-binding protein in regulation of insulin responses and lipid homeostasis. Biochim. et Biophys. Acta (BBA) Mol. Cell Biol. Lipids. 2012;1821:168\u2013176. doi: 10.1016/j.bbalip.2011.07.002.", "ArticleIdList": ["10.1016/j.bbalip.2011.07.002", "PMC3204314", "21782034"]}, {"Citation": "Eleazu C., Charles A., Eleazu K., Achi N. Free fatty acid receptor 1 as a novel therapeutic target for type 2 diabetes mellitus-current status. Chem. Biol. Interact. 2018;289:32\u201339. doi: 10.1016/j.cbi.2018.04.026.", "ArticleIdList": ["10.1016/j.cbi.2018.04.026", "29704509"]}, {"Citation": "Qiang G., Xue S., Yang J.J., Du G., Pang X., Li X., Goswami D., Griffin P.R., Ortlund E.A., Chan C.B. Identification of a small molecular insulin receptor agonist with potent antidiabetes activity. Diabetes. 2014;63:1394\u20131409. doi: 10.2337/db13-0334.", "ArticleIdList": ["10.2337/db13-0334", "PMC3964510", "24651808"]}, {"Citation": "Chen L., Lu X., El-Seedi H., Teng H. Recent advances in the development of sesquiterpenoids in the treatment of type 2 diabetes. Trends Food Sci. Technol. 2019;88:46\u201356. doi: 10.1016/j.tifs.2019.02.003.", "ArticleIdList": ["10.1016/j.tifs.2019.02.003"]}, {"Citation": "Brahmachari G. Bio-flavonoids with promising antidiabetic potentials: A critical survey. Res. Signpost. 2011;661:187\u2013212."}, {"Citation": "Cazarolli L.H., Zanatta L., Alberton E.H., Reis Bonorino Figueiredo M.S., Folador P., Damazio R.G., Pizzolatti M.G., Mena Barreto Silva F.R. Flavonoids: Cellular and molecular mechanism of action in glucose homeostasis. Mini Rev. Med. Chem. 2008;8:1032\u20131038. doi: 10.2174/138955708785740580.", "ArticleIdList": ["10.2174/138955708785740580", "18782055"]}, {"Citation": "Nicolle E., Souard F., Faure P., Boumendjel A. Flavonoids as promising lead compounds in type 2 diabetes mellitus: Molecules of interest and structure-activity relationship. Curr. Med. Chem. 2011;18:2661\u20132672. doi: 10.2174/092986711795933777.", "ArticleIdList": ["10.2174/092986711795933777", "21568900"]}, {"Citation": "Testa R., Bonfigli A., Genovese S., De Nigris V., Ceriello A. The possible role of flavonoids in the prevention of diabetic complications. Nutrients. 2016;8:310. doi: 10.3390/nu8050310.", "ArticleIdList": ["10.3390/nu8050310", "PMC4882722", "27213445"]}, {"Citation": "Vinayagam R., Xu B. Antidiabetic properties of dietary flavonoids: A cellular mechanism review. Nutri. Metab. 2015;12:60. doi: 10.1186/s12986-015-0057-7.", "ArticleIdList": ["10.1186/s12986-015-0057-7", "PMC4690284", "26705405"]}, {"Citation": "Google Scholar.  [(accessed on 15 November 2018)]; Available online:  https://scholar.google.com."}, {"Citation": "ScienceDirect.  [(accessed on 15 November 2018)]; Available online:  https://www.sciencedirect-com.uplib.idm.oclc.org/"}, {"Citation": "FooDB.  [(accessed on 15 November 2018)]; Available online:  Foodb.ca."}, {"Citation": "Kim S., Thiessen P.A., Bolton E.E., Chen J., Fu G., Gindulyte A., Han L., He J., He S., Shoemaker B.A. PubChem substance and compound databases. Nucl. Acids Res. 2015;44:D1202\u2013D1213. doi: 10.1093/nar/gkv951.", "ArticleIdList": ["10.1093/nar/gkv951", "PMC4702940", "26400175"]}, {"Citation": "ACD/Chemsketch. Advanced Chemistry Development, Inc.; Toronto, ON, Canada: 2015. version 12.02."}, {"Citation": "Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u20132504. doi: 10.1101/gr.1239303. Cytoscape, version 3.4.0; Cytoscape Consortium: San Diego, CA, USA, 2016.", "ArticleIdList": ["10.1101/gr.1239303", "PMC403769", "14597658"]}, {"Citation": "Schr\u00f6dinger Canvas Suite. Schr\u00f6dinger, LLC; New York, NY, USA: 2019. version 4.0.012."}]}], "History": [{"Year": "2019", "Month": "9", "Day": "30"}, {"Year": "2019", "Month": "11", "Day": "1"}, {"Year": "2019", "Month": "11", "Day": "4"}, {"Year": "2019", "Month": "11", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["31703341", "PMC6891552", "10.3390/molecules24224030", "molecules24224030"]}}]}